Late Stage Investors & VC Firms in New York
247 firms in this list, with a median first check of $1M. 54 of them lead rounds. Generated from verified public data and updated continuously.
Adjuvant Capital
New YorkSeries A–Late Stage$10M – $25M
19 people
Motive Partners
New YorkPre-Seed–Late Stage$1M – $10M
3 people
Alkeon Innovation
New YorkPre-Seed–Late Stage
5 people
Owl Rock Capital
New YorkGrowth–Late Stage$20M – $250M
20 people
Brookfield Asset Management
New YorkGrowth–Late Stage
23 people
BIOSPRING PARTNERS
New YorkGrowth–Late Stage
22 people
Vedanta Capital
New YorkSeed–Late Stage
10 people
New Mountain Capital
New YorkGrowth–Late Stage
6 people
Marker
New YorkSeed–Late Stage
16 people
The Global Emerging Markets Group (GEM)
New YorkGrowth–Late Stage
17 people
Redesign Health
New YorkSeed–Late Stage
18 people
Blue Owl Capital
New YorkGrowth–Late Stage
19 people
Communitas Capital Partners
New YorkPre-Seed–Late Stage
9 people
Galaxy Interactive
New YorkPre-Seed–Late Stage$1M – $20M
9 people
StarVest Partners
New YorkGrowth–Late Stage
19 people
Cohen Circle
New YorkPre-Seed–Late Stage
12 people
VCFA Group
New YorkGrowth–Late Stage$150K – $2.5M
11 people
Ally Bridge Group
New YorkSeed–Late Stage
7 people
Das & Co.
New YorkSeed–Late Stage
12 people
Trajectory Ventures
New YorkSeed–Late Stage
1 person
8090 Industries
New YorkSeries B–Late Stage
12 people
Innovatus Capital Partners
New YorkSeed–Late Stage
19 people
Atalaya Capital
New YorkPre-Seed–Late Stage
18 people
Silas Capital Partners
New YorkSeed–Late Stage$100K – $15M
7 people
Related lists
Investors & VC Firms in North America (13808)Investors & VC Firms in United States (12951)Seed Investors & VC Firms (10929)Series A Investors & VC Firms (8112)Pre-Seed Investors & VC Firms (5907)Seed Investors & VC Firms in North America (5670)Investors & VC Firms in Europe (5511)Seed Investors & VC Firms in United States (5100)Growth Investors & VC Firms (4840)Series A Investors & VC Firms in North America (4569)
Data sourced from public filings and firms' own websites — see our methodology.























































































